Evidence map›Paper›PMID 27857881›Full record

ArticleCurrent clinical microbiology reports2016

Nucleic acid sensing and innate immunity: signaling pathways controlling viral pathogenesis and autoimmunity.

Laura R H Ahlers, Alan G Goodman

Abstract read
In one paragraph

Article in Current clinical microbiology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Cyclin-dependent kinase activity is required for type I interferon production.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Laura R H AhlersSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, 100 Dairy Rd., Biotechnology/Life Sciences Rm. 135, Pullman, WA 99164; Protein Biotechnology Graduate Training Program, Washington State University, 100 Dairy Rd., Biotechnology/Life Sciences Rm. 135, Pullman, WA 99164.
Alan G GoodmanSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, 100 Dairy Rd., Biotechnology/Life Sciences Rm. 135, Pullman, WA 99164.
Washington State University · US

Funding

TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
Conserved Immune Response to Sensing Cytosolic DNAR00AI106963 · NIAID · WASHINGTON STATE UNIVERSITY · PI GOODMAN, ALAN GABRIEL · 2014 to 2015
$498k
NIAID NIH HHS R00 AI106963NIGMS NIH HHS T32 GM008336
6 · The paper itself

Abstract

Innate immunity refers to the body's initial response to curb infection upon exposure to invading organisms. While the detection of pathogen-associated molecules is an ancient form of host defense, if dysfunctional, autoimmune disease may result. The innate immune response during pathogenic infection is initiated through the activation of receptors recognizing conserved molecular patterns, such as nucleic acids from a virus' genome or replicative cycle. Additionally, the host's own nucleic acids are capable of activating an immune response. Therefore, it follows that the nucleic acid-sensing pathways must be tightly controlled to avoid an autoimmune response from recognition of self, yet still be unimpeded to respond to viral infections. In this review, we will describe the nucleic acid sensing pathways and how they respond to virus infection. Moreover, we will discuss autoimmune diseases that develop when these pathways fail to signal properly and identify knowledge gaps that are prime for interrogation.

Indexed as

autoimmunitycGASinterferonMDA5RIG-ISTING

Identifiers

PMID27857881
PMCPMC5108628
OpenAlexW2463358063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.